Ligand Pharmaceuticals, Inc. (LGND)

201.90 -4.50 (-2.18%) USD  |  NASDAQ  |  Mar 06, 16:00
201.58 -0.32 (-0.16%) After-Hours: 20:00
More

Ligand Pharmaceuticals Payables and Accrued Expenses (Quarterly)

Payables and Accrued Expenses (Quarterly) Chart

View Payables and Accrued Expenses (Quarterly) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Payables and Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Payables and Accrued Expenses (Quarterly) Benchmarks

View Payables and Accrued Expenses (Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
Globus Medical, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade